Evergreen Theragnostics finishes New Jersey manufacturing plant
Facility meets cGMP standards for radiopharmaceutical production
Evergreen Theragnostics, Inc., a radiopharmaceutical contract development and manufacturing organization (CDMO), recently celebrated the grand opening of its newly built 14,000 square-foot manufacturing facility in Springfield, NJ.
With this new site, the CDMO says it is prepared to meet the manufacturing needs of companies developing and commercializing radiopharmaceuticals, ranging from preclinical and early-stage clinical trials to full scale commercial manufacturing of approved products. The facility meets global cGMP (current good manufacturing practice) standards for radiopharmaceutical manufacturing, including therapeutic and centrally distributed diagnostic products. It consists of seven commercial scale production suites, research space, numerous sterility lines, quality control, material storage and packaging space.
The facility uses a fully electronic QMS (quality management system) and LIMS (laboratory information management system), and is licensed to safely handle a variety of radionuclides.
